As evidence generation becomes more advanced and integrated into Medical Affairs strategic plans, there is a greater need to maximize its impact by leveraging emerging digital technologies to communicate complex clinical and nonclinical data.
In this episode, listeners will better understand what innovative content is in the context of Medical Information while setting expectations of HCPs in accessing innovative content.
Advisory boards bring together a selection of key opinion leaders to discuss a topic important to a life sciences company. Here is how to use engagement technologies to generate actionable insights from your next ad board.
All industries are rushing to harness rich data in order to drive progress, but how can the many data sources help Medical Affairs to show impact and drive improved patient outcomes?
In part three of this four-part series, we will discuss:
This Webinar series explores the fundamental concept of big data in Medical Affairs, from which sources can we retrieve this, what are the broader considerations when utilizing data in health and what impact this can have on our organizations, physicians, and patients, now and in the future. These presentations will feature real-world cases that are relevant to regional and country Medical Affairs leaders, in order to highlight long-term aspirational and short-term tangible projects.
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS speaks with Robin Winter-Sperry and Robert Kersting, PharmD, Global Head, Scientific Alliances, Novartis, about the need for multi-stakeholder partnerships.
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS speaks with Jim Wilkinson, PhD, Vice President, Global & US Medical Affairs, Amgen, about how to develop Medical Affairs talent into tomorrow’s leaders.
While the value of patient engagement is increasingly recognised in the clinical and launch phases of drug development, it is still a relatively new concept to involve patients in the early discovery phase. By understanding the burden of disease and patient’s aspirations for new treatments from the outset, pharma companies can ensure they are developing medicines that matter to patients. As experts in the disease area and therapeutic landscape, Medical Affairs are well placed to initiate and develop effective patient partnerships to ensure that the patient voice is incorporated during early discovery and beyond.
In this webinar we will explore practical approaches to engaging patients in early development, introducing key resources and discussing best practices. These discussions will be tailored to meet the needs of all Medical Affairs colleagues, regardless of experience.
MAPS announces the election of Dr. Danie du Plessis as Chair of the MAPS Board of Directors. Du Plessis is currently Executive Vice-President (EVP) & Head of Medical Affairs at Kyowa Kirin International and is a senior pharmaceutical executive with 30 years’ experience.
Medical Information is a critical conduit with healthcare providers who interact with field sales or scientific professionals or who seek scientific information independently. In this customer-facing and customer-focused capacity, Medical Information is the “face” of the manufacturer to many external customers and serves to facilitate the safe and effective use of the marketed products. Medical Information has a significant role in supporting the information needs of HCPs, patients, and caregivers through the provision of medical information in response to unsolicited questions about the manufacturer’s products and strives to provide excellent customer service based on the customer’s expectations through a variety of channels. MedInfo also partners with internal business functions, including, but not limited to: Medical Affairs, Pharmaceutical and Clinical Development, Quality Assurance, Manufacturing, Publication Planning, Safety, Business Technology, Finance, Legal, Regulatory, and Commercial/Marketing.
This Standard and Guidance is intended to inform learners about the Medical Information (MI) function, strategic direction, and operations across multiple geographies.
This White Paper draws on the expertise of 10 senior Medical Affairs leaders across diverse global organizations to describe the role of Medical Affairs in ensuring the MedTech industry meets the challenges of high-quality evidence, objective measures, changes in the healthcare landscape, and more.